Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Current Leases (2019 - 2026)

OptimizeRx's Current Leases history spans 7 years, with the latest figure at $193000.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 14.88% to $193000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $193000.0, a 14.88% increase, with the full-year FY2025 number at $193000.0, up 14.88% from a year prior.
  • Current Leases hit $193000.0 in Q4 2025 for OptimizeRx, down from $207000.0 in the prior quarter.
  • Over the last five years, Current Leases for OPRX hit a ceiling of $233000.0 in Q1 2024 and a floor of $14545.0 in Q2 2023.
  • Historically, Current Leases has averaged $134541.4 across 5 years, with a median of $114830.0 in 2021.
  • Biggest five-year swings in Current Leases: crashed 83.41% in 2023 and later soared 1405.67% in 2024.
  • Tracing OPRX's Current Leases over 5 years: stood at $90982.0 in 2021, then fell by 1.19% to $89902.0 in 2022, then surged by 146.94% to $222000.0 in 2023, then fell by 24.32% to $168000.0 in 2024, then grew by 14.88% to $193000.0 in 2025.
  • Business Quant data shows Current Leases for OPRX at $193000.0 in Q4 2025, $207000.0 in Q3 2025, and $209000.0 in Q2 2025.